ROBERT DROUIN: Open Payments
NPI 1629168943 · TORRINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$574 in 18 payments from 8 companies in 2025. Trend: 2023 $429 · 2024 $757 · 2025 $574
Food & beverage: $574
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories | 3 | $172 |
| E.R. Squibb & Sons, L.L.C. | 5 | $112 |
| Madrigal Pharmaceuticals | 1 | $87 |
| Novartis Pharmaceuticals Corporation | 4 | $69 |
| Merck Sharp & Dohme LLC | 2 | $52 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $28 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 1 | $27 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $27 |
Products named: CARDIOMEMS, REZDIFFRA, LEQVIO, ELIQUIS, VERQUVO, CAMZYOS, JARDIANCE, LifeVest.
Industry payments across CT — which companies pay providers there.
